ProCEED Pilot Study (Prostate Cancer Study of Ethnicity, Exercise and Diet)

The second year (2007) of ProCEED study funding was dedicated to subject enrollment. Interim results are available for most parameters except those that were planned to be analyzed at study end. At the end of the reporting period, there were 62 patients enrolled (56 prostate cancer cases and 6 controls). Among the 62 patients there was a 79% subject retention rate for the dietary follow-up calls. Interim analyses indicate that the study sample thus far is elderly, obese, and predominantly African-American. Among the prostate cancer cases most of the cases were diagnosed in stage T2 and had Gleason scores of 7 or less. The most frequently used prostate cancer treatment was hormonal therapy. The third year (2008) of funding will be dedicated to: continued subject enrollment, dietary analyses, laboratory assays, statistical analysis, and a written summary.
The original document contains color images.